当前发展计划


BioMark Technologies Inc.

  • Complete antibody development at UBC’s Biomedical Research Centre
  • Commence prototype development
  • Patent new discoveries
  • File ITA with Health Canada for internal standard developed for use in LC MS MS metabolite detection
  • Develop new compound and Mab for new additional substrate
  • Develop phase III trial design/markets and indications post pre-trial at SBRC in Manitoba Canada.
  • Submit revised protocol to Health Canada
  • Seek other detection technologies to reduce costs in the future
  • Seek phase III clinical trial centres in Canada and abroad
  • Kit placement in test markets
  • Accelerate point of care IVD kit post generation of monoclonal antibodies
  • Conduct double blinded studies for diagnostic systems are under development
  • Expand existing team at BioMark
  • Seek development and commercialization partners
  • Start and complete lung cancer response to treatment studies at CancerCare Manitoba

    • BioMark China International

  • 骨诱导人工骨 - 新合作医院开发
  • VDS互创材料 - 新合作医院开发
  • REPARO品牌推进，寻找更多合作伙伴
  • 光福农场产品进入香港、澳门等市场
  • BEAUTEE COLLAGEN系列产品市场推进
  • 顶棘沙棘果汁深入研发